Medicines: Bortezomib

All About Velcade (Bortezomib) for Myeloma patients

HealthTree University Myeloma

Bortezomib Leads to More Complete Remissions in Patients With High-Risk Follicular Lymphoma

American Society of Hematology

Bortezomib and lenalidomide as first-line treatment for older patients with myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Understanding your treatment: Velcade therapy

charlottecancer

Novel Anti-Cancer Agents for Multiple Myeloma

Mechanisms in Medicine

Found in Translation: The Tale of the Cancer Drug Bortezomib (Velcade)

Harvard Medical School

PROTEOSOME INHIBITORS Mechanism of Action. Pharmacology. Bortezomib, Ixazomib. Myeloma treatment.

Proteasome inhibitor drugs

The impact of bortezomib dose adjustment in the OPTIMISMM study

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Bijal Shah on Bortezomib's Impact on Treatment of MCL

Dr. Goy on Bortezomib in MCL Treatment

OPTIMAL: bortezomib-based therapy vs thalidomide-based therapy in myeloma with renal failure

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Goy on BR Plus Bortezomib for MCL Treatment

Velcade (bortezomib) - Drug Rx Information

Global Health Information

SWOG S0777 trial: lenalidomide, dexamethasone and bortezomib for the treatment of MM

VJHemOnc – Video Journal of Hematology & HemOnc

Trial results and drug combinations for bortezomib in multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

The Truth About Myeloma Treatment Side Effects

Patient Empowerment Network

Dr. Kumar Discusses MLN9708 and Bortezomib in Multiple Myeloma

Targeted Oncology

Results of Iberdomide in Combination with Dex and Daratumumab or Bortezomib in Patients with RRMM

International Myeloma Foundation

Treatment & Management of Newly Diagnosed Multiple Myeloma